MedPath

Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease

Not Applicable
Completed
Conditions
Psychological Stress
Cognitive Ability, General
Parenting
Sickle Cell Disease
Interventions
Behavioral: Play therapy
Other: Problem solving skills
Registration Number
NCT02394899
Lead Sponsor
The University of The West Indies
Brief Summary

There are all significant risk factors for poor early cognitive development and, as such, neurocognitive deficits have been demonstrated in pre-school children with sickle cell disease (SCD). This project assesses the efficacy of using an evidence-based early stimulation program, combined with components to help parents cope with stress, delivered during six routine monthly clinic visits to parents of children with sickle cell disease. It is hoped that this innovation will improve parental psychological outcomes, as well as child developmental outcomes.

Detailed Description

Children with sickle cell disease (SCD) are at risk of various complications, many of which arise suddenly and call on the problem solving skills of their parents. They are also at risk of neurocognitive delays; these may become evident during the pre-school years. Previous research by this group has demonstrated improved developmental outcomes after parental interventions incorporating play techniques in high risk and healthy pre-school children. The aim of the study is to determine usefulness in children with SCD of similar developmental interventions augmented by lessons in problem solving.

The study is a randomized controlled trial. Parents of all infants with Hb SS (homozygous sickle cell disease) or Sβ0 -thalassemia disease identified by newborn screening during the initial year of the study will be invited to participate. They will be randomized to intervention or control. Parental stress, infant's development and hemoglobin levels will be measured at recruitment and again after six months. The intervention will occur during monthly Penadur (intramuscular Benzathine Penicillin) visits and will include supervised play with their children using an inexpensive toy and participation in solving a problem which may arise as they parent their child with SCD. At the end of the study, all control dyads will also be given the toys used in the intervention. All parents will be given the results of their children's developmental assessments and appropriate referrals made if deficits are identified.

The study is minimal risk. Every effort will be made to maintain patient confidentiality. Respect for, and the maximum protection of the best interests of the research subjects will be maintained.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Infant has sickle cell disease: SS or Sβ0 thalassemia
  • Attending Sickle Cell Unit, Jamaica for routine care
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IntervenedPlay therapyParents receive training in problem solving skills and play therapy with their infants.
IntervenedProblem solving skillsParents receive training in problem solving skills and play therapy with their infants.
Primary Outcome Measures
NameTimeMethod
Infant's development quotient (Griffiths Developmental Scale)6 months

Griffiths Developmental Scale

Parental stress, depression and coping (Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents)6 months

Questionnaires to assess: Pediatric Inventory for Parents; CES-D; Coping Health Inventory for parents

Parental problem solving skills (Social Problem Solving Inventory)6 months

Using Social Problem Solving Inventory: Questionnaires

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sickle Cell Unit, University of West Indies, Mona Campus

🇯🇲

Kingston 7, Jamaica

© Copyright 2025. All Rights Reserved by MedPath